Vetmedin CA1 Chewable Tablets (Pimobendan) - 5mg

Helps Delay Heart Failure in Dogs

Product Description

VETMEDIN®-CA1 (pimobendan) Chewable Tablets are a prescription cardiac medication indicated for dogs diagnosed with Stage B2 preclinical myxomatous mitral valve disease. The product is designed to help delay the onset of congestive heart failure by improving cardiac function and supporting balanced blood vessel dilation. The beef-flavored chewable format supports palatability and consistent long-term administration under veterinary supervision.

Benefits

• Dual Action Support: Improves heart muscle contraction while promoting balanced vasodilation to reduce cardiac workload in affected dogs.
• Disease Progression Delay: Demonstrated to significantly delay progression to congestive heart failure in dogs with Stage B2 MMVD.
• Veterinary Recommended: Included by ACVIM cardiology specialists as part of first-line therapy for Stage B2 MMVD dogs.
• High Palatability: Beef-flavored chewable tablets promote voluntary consumption and improve long-term treatment compliance.

Variants

• VETMEDIN®-CA1 Chewable Tablets 1.25 mg
• VETMEDIN®-CA1 Chewable Tablets 5 mg

Ingredients

Active Ingredients

Pimobendan

How to Use

Recommended-Dosage Chart

Dosage & Administration Instructions

• Prescription Requirement: Is labeled as a prescription-only cardiac medication and must be used by or on the order of a licensed veterinarian.
• Approved Daily Dose: Is labeled for a total daily dose of 0.23 mg per pound body weight, divided into two administrations.
• Split Dosing Schedule: The labeled daily dose is divided into two portions administered approximately twelve hours apart.
• Tablet Flexibility: Scored tablets allow dosing to the nearest half-tablet increment using whole or split tablets.

Disclaimer: This dosage information is provided by the manufacturer. Always consult your veterinarian before administering or adjusting any supplement for your pet.

Additional Information

Precautions

• Restricted Use: Intended only for dogs with confirmed Stage B2 preclinical myxomatous mitral valve disease.
• Diagnostic Confirmation: Diagnosis should include comprehensive cardiac evaluation such as radiography and echocardiography.
• Medication Interactions: Has not been evaluated for safety in dogs receiving other concurrent heart medications.

Possible Side Effects

• Gastrointestinal Signs: Vomiting and diarrhea have been reported in some dogs receiving pimobendan therapy.
• Respiratory Changes: Coughing may occur and is commonly associated with disease progression in MMVD.
• Neurologic Events: Seizures have been reported as uncommon adverse reactions not related to disease progression.

Storage Information

• Room Temperature: Labeled for storage between 68°F and 77°F with short-term temperature excursions permitted.
• Secure Storage: Should be kept in a secure location to prevent accidental ingestion by animals.

Shipping & Return

We offer ground, express, priority, and international delivery; see our shipping policy for details.

For return instructions or product concerns, please refer to our detailed refund policy.

Prescription items are NON-RETURNABLE and NON-REFUNDABLE.

Frequently Asked Questions

Q1: What condition is VETMEDIN®-CA1 prescribed for?

Ans: VETMEDIN®-CA1 is indicated for dogs with Stage B2 preclinical myxomatous mitral valve disease to help delay the onset of congestive heart failure. Its use is based on ACVIM consensus guidelines and FDA conditional approval labeling.

Q2: Is VETMEDIN®-CA1 approved by the FDA?

Ans: VETMEDIN®-CA1 is conditionally approved by the FDA pending full demonstration of effectiveness. Conditional approval confirms product safety, quality, and a reasonable expectation of effectiveness under labeled conditions.

Q3: Can VETMEDIN®-CA1 be used in dogs without heart enlargement?

Ans: Manufacturer labeling advises against use in dogs without cardiomegaly, including Stage A or B1 MMVD, due to potential cardiac risks associated with exaggerated hemodynamic responses.

Q4: Why is veterinary supervision required for this product?

Ans: VETMEDIN®-CA1 is a prescription cardiac medication that requires proper diagnosis, dosing oversight, and monitoring by a licensed veterinarian to ensure safe and appropriate use.